Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

BACKGROUND: Better treatments for glioblastoma (GBM) patients, in particular in the recurrent setting, are urgently needed. Clinical trials performed in Brazil indicated that intranasal delivery of perillyl alcohol (POH) might be effective in this patient group. NEO100, a highly purified version of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879254/
https://www.ncbi.nlm.nih.gov/pubmed/33604574
http://dx.doi.org/10.1093/noajnl/vdab005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879254/
https://www.ncbi.nlm.nih.gov/pubmed/33604574
http://dx.doi.org/10.1093/noajnl/vdab005

Ejemplares similares